Welcome to our dedicated page for Trupanion SEC filings (Ticker: TRUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trupanion, Inc. (NASDAQ: TRUP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its business as a provider of medical insurance for cats and dogs. These SEC filings cover areas such as financial performance, risk factors, capital structure, governance, and material agreements that shape the company’s operations and its TRUP stock profile.
Key filings for Trupanion include annual reports on Form 10-K, which describe its subscription and other business segments, geographic reach, insurance entities, and risk considerations; and quarterly reports on Form 10-Q, which update investors on revenue from subscription and other business, enrolled pet counts, net income or loss, cash flows, and technology and development spending. Current reports on Form 8-K disclose material events, such as new credit agreements, earnings releases, and board appointments.
For example, Trupanion has used Form 8-K to report entering into a credit agreement with PNC Bank that provides term loan and revolving credit facilities secured by substantially all of the company’s and certain subsidiaries’ assets, and to announce the appointment of a new independent director to its board. Other 8-K filings reference the issuance of press releases detailing quarterly financial results.
Investors can also review Trupanion’s disclosures on non-GAAP financial measures, forward-looking statements, and risk factors, which are discussed in its periodic reports and referenced in earnings-related filings. These documents explain how the company views metrics such as adjusted EBITDA, net acquisition cost, and cash flow, and outline factors that could affect future performance, including claims trends, retention, regulatory constraints, and capital requirements.
On this page, Stock Titan presents Trupanion’s SEC filings alongside AI-powered summaries that highlight the main points of lengthy documents, such as 10-K and 10-Q reports. Users can quickly identify important information on segment performance, debt arrangements, and governance changes, while still having access to the full text of each filing for deeper review.
Trupanion, Inc. Chief Financial Officer Fawwad Qureshi reported multiple share transactions involving common stock and restricted stock units. On February 25, 2026, he exercised 3,750 restricted stock units that convert into common stock on a one-for-one basis and received 3,750 common shares.
On the same date, he sold 4,645 common shares in an open-market transaction at a weighted average price of $25.61 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on May 19, 2025, meaning he had no discretion over timing. The weighted average sale price reflects multiple trades between $25.35 and $25.89 per share.
In addition, 913 common shares were withheld by the company at $26.70 per share to cover income tax obligations on the RSU vesting, which is described as not representing a sale. After these transactions, he directly owned 2,837 common shares and 26,250 RSUs.
TRUPANION, INC. executive Simon Wheeler, EVP, Trupanion International, reported routine equity compensation activity involving restricted stock units and common shares. On February 25, 2026, 322 restricted stock units were exercised and converted into 322 shares of common stock at a price of $0.00 per share.
Following this conversion, Wheeler directly owned 23,238 shares of common stock before a portion was withheld for taxes. Separately, 151 common shares were disposed of at $26.70 per share to satisfy income tax withholding and remittance obligations tied to the RSU vesting, leaving Wheeler with 23,087 directly owned common shares. Footnotes clarify this tax-related disposition does not represent an open-market sale by Wheeler.
TRUPANION, INC. Chief Legal Officer Asher Bearman reported routine equity compensation activity involving restricted stock units that convert into common stock on a one-for-one basis. On February 25, 2026, RSU conversions delivered 180 and 125 common shares at a stated price of $0.00 per share.
To satisfy income tax withholding tied to these vestings, the company withheld 68 and 48 common shares at $26.70 per share, which footnotes state do not represent sales by the insider. Following these transactions, Bearman directly owned 70,479 shares of Trupanion common stock.
TRUPANION, INC. Chief Operating Officer John R. Gallagher reported routine equity compensation activity involving restricted stock units that vested and converted into common stock. On February 25, 2026, RSUs converted into common shares on a one-for-one basis at no exercise price.
Gallagher acquired common stock through derivative exercises and had a portion of the newly vested shares withheld by the company to cover income tax obligations at a price of $26.70 per share, which the footnotes clarify does not represent an open-market sale. After these transactions, he directly held 37,670 shares of common stock.
Trupanion, Inc. Chief Revenue Officer Emily Dreyer reported routine equity activity linked to restricted stock units (RSUs). On February 25, 2026, RSUs covering 1,482 and 343 units converted into the same number of common shares on a one-for-one basis.
To cover income tax withholding on these vestings, 360 and 83 common shares were withheld by Trupanion at a price of $26.70 per share, which the footnotes state does not represent a sale by Dreyer. After these transactions, Dreyer directly owned 43,419 common shares.
TRUPANION, INC. executive Steve Weinrauch, EVP North America & Vet Strategy, reported multiple equity transactions on February 25, 2026 linked to previously granted restricted stock units (RSUs). Several RSU awards vested and converted into common stock on a one-for-one basis, increasing his direct holdings.
In connection with these vestings, the issuer withheld 129 and 9 shares of common stock at $26.70 per share to satisfy income tax withholding and remittance obligations, which the disclosure states do not represent sales by Weinrauch. He also completed an open-market or private sale of 85 common shares at $26.70 per share. Following these transactions, he directly owned 72,559 shares of Trupanion common stock.
John Gallagher filed a Form 144 reporting proposed sales of restricted common stock and recent dispositions. The filing lists proposed restricted shares of 430 (restricted on 02/25/2023) and 4,853 (restricted on 02/22/2026), and shows sales during the prior three months of 430 shares for $13,618.10 on 01/28/2026, 430 shares for $16,146.50 on 12/29/2025, and 6,383 shares for $222,282.87 on 11/28/2025.
FAWWAD QURESHI filed a Form 144 reporting an intended sale of 2,837 restricted common shares on 02/25/2026. The filing also shows 4,645 common shares were sold in the prior three months on 02/25/2026 for an aggregate of $118,958.45.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting the intended sale of 4,645 shares of Common Stock of TRUP issued as Restricted Stock on 02/22/2026. The filing also lists a prior sale by Fawwad Qureshi of 6,202 shares on 11/26/2025 for $219,836.09.
Trupanion, Inc. received an amended Schedule 13G/A from Tarmac DLTFM Limited reporting 0 shares beneficially owned of Trupanion common stock, representing 0% of the class. The filing identifies Guernsey as the filer’s citizenship and is dated 02/17/2026; it was signed on 02/25/2026.